The Lancet Gastroenterology & Hepatology in conversation with
76 episodes - English - Latest episode: about 2 months ago -Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.
A monthly audio companion to the journal, this podcast covers a broad range of topics, from predicting clinical outcomes in NAFLD to immunosuppressant withdrawal in patients with Crohn’s disease, the primary antibiotic resistance of Helicobacter pylori to surgical versus non-surgical management of malignant bowel obstruction, and more.
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
Mads Israelsen on validating the new steatotic liver disease nomenclature in people with excessive alcohol intake
March 12, 2024 15:00 - 16 minutes - 11.5 MBMads Israelsen (Odense University Hospital) discusses a study to validate the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00443-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicalj...
Louise Dye on the role of expectancy and gluten in non-coeliac gluten sensitivity
March 01, 2024 15:00 - 23 minutes - 16 MBLouise Dye (University of Leeds) discusses a trial exploring the role of expectancy and gluten ingestion on symptoms in people with non-coeliac gluten sensitivity. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00317-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https:/...
Tzu-Chan Hong on the primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region
December 19, 2023 11:00 - 14 minutes - 10.1 MBTzu-Chan Hong (National Taiwan University Cancer Centre) discusses a systematic review and meta-analysis on primary antibiotic resistance of Helicobacter pylori between 1990 and 2022 in the Asia-Pacific region. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00281-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https...
Sarah Moen on metachronous colorectal cancer risk according to Lynch syndrome pathogenic variant after colectomy
November 29, 2023 16:00 - 14 minutes - 10.2 MBSarah Moen (Erasmus University Medical Center) discusses a retrospective cohort study examining the risk of metachronous colorectal cancer after partial or extensive colectomy in carriers of different pathogenic Lynch syndrome variants. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00228-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagra...
Anna Emilie Kann on the causes of mortality in patients with alcohol-related liver disease
October 12, 2023 16:00 - 16 minutes - 11.2 MBAnna Emilie Kann (Zealand University Hospital, Denmark) discusses a population-based study done in Denmark exploring the causes of mortality in patients with alcohol-related liver disease. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00192-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thela...
Robert Krouse on surgical versus non-surgical management of malignant bowel obstruction
September 13, 2023 10:00 - 16 minutes - 11.4 MBRobert Krouse (University of Pennsylvania) discusses the pragmatic S1316 trial of surgical versus non-surgical management for patients with malignant small bowel obstruction. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00191-7/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljour...
Marc Rothenberg on a trial of benralizumab in eosinophilic gastritis
August 10, 2023 22:00 - 14 minutes - 9.97 MBMarc Rothenberg (University of Cincinnati College of Medicine) discusses a new trial assessing the efficacy and safety of benralizumab in patients with eosinophilic gastritis, and how the surprising findings might change our understanding of eosinophilic gastrointestinal diseases. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00145-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversation on social! Follow us today at... h...
Michael Pavlides on non-invasive tests for predicting clinical outcomes in non-alcoholic fatty liver disease
July 12, 2023 22:00 - 17 minutes - 12.2 MBMichael Pavlides (University of Oxford) discusses work by the LITMUS Consortium on the prognostic performance of non-invasive tests in patients with non-alcoholic fatty liver disease. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00017-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetme...
Jasmohan Bajaj on global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis
June 07, 2023 22:00 - 12 minutes - 8.82 MBJasmohan Bajaj (Virginia Commonwealth University and Central Virginia Veterans Healthcare System, Richmond, VA, USA), on behalf of the CLEARED Consortium, discusses a prospective observational cohort study examining global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00098-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas Continue this conversation o...
Adelina Artenie on the incidence of HIV and HCV in people who inject drugs
May 10, 2023 22:00 - 17 minutes - 11.9 MBAdelina Artenie (University of Bristol, UK) discusses a systematic review and meta-analysis exploring the incidence of HIV and HCV among people who inject drugs, and associations with age and sex or gender. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00018-3/fulltext?dgcid=buzzsprout_icw_podcast_langas_lancet Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://f...
Johan Burisch on the costs of inflammatory bowel disease in high-income settings
April 12, 2023 10:00 - 20 minutes - 13.8 MBJohan Burisch (Copenhagen University Hospital, Denmark) discusses the findings and recommendations of The Lancet Gastroenterology & Hepatology Commission on the cost of inflammatory bowel disease in high-income settings. Read the Commission here: The cost of inflammatory bowel disease in high-income settings Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://link...
Edouard Louis on the SPARE trial of infliximab or immunosuppressant withdrawal in Crohn’s disease
February 08, 2023 23:00 - 21 minutes - 14.8 MBEdouard Louis (University Hospital CHU of Liège) discusses the SPARE randomised controlled trial of infliximab or concomitant immunosuppressant withdrawal in patients with Crohn’s disease. Read the full article: Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE) Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thel...
Paula Ghaneh on the ESPAC5 trial of neoadjuvant therapy in borderline resectable pancreatic cancer
January 23, 2023 15:00 - 20 minutes - 14 MBPaula Ghaneh (University of Liverpool) discusses the ESPAC5 randomised controlled trial of short-course neoadjuvant therapy compared with immediate surgery for patients with borderline resectable pancreatic ductal adenocarcinoma. Read the full article: Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5) Continue this conversation on social! Follow us today...
Dan Turner on vedolizumab in children with IBD
January 06, 2023 10:00 - 14 minutes - 10.2 MBDan Turner (Shaare Zedek Medical Center) discusses the VEDOKIDS study on the safety, effectiveness, and dosing of vedolizumab in children with IBD. Read the full article: Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS) Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lance...
Simon Baunwall on faecal microbiota transplantation for first or second Clostridioides difficile infection
November 09, 2022 23:00 - 15 minutes - 10.6 MBSimon Baunwall (Aarhus University Hospital) discusses the EarlyFMT trial, a randomized placebo-controlled trial of faecal microbiota transplantation for first or second Clostridioides difficile infection. Read the full article: Faecal microbiota transplantation for first or second Clostridioides difficile infection (EarlyFMT) Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljo...
James Alexander on immune responses to COVID-19 vaccination in patients with IBD
October 05, 2022 22:00 - 13 minutes - 9.51 MBJames Alexander (Imperial College London) discusses the latest findings from the VIP case-control study, which is investigating COVID-19 vaccine immune responses in immunosuppressed patients with inflammatory bowel disease. Read the full article: COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP) Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https:...
James Alexander immune responses to COVID-19 vaccination in patients with IBD
October 05, 2022 22:00 - 13 minutes - 9.51 MBJames Alexander (Imperial College London) discusses the latest findings from the VIP case-control study, which is investigating COVID-19 vaccine immune responses in immunosuppressed patients with inflammatory bowel disease. Read the full article: COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP)
Filip Knop on liraglutide for bile acid diarrhoea
September 07, 2022 22:00 - 15 minutes - 10.4 MBFilip Knop (University of Copenhagen) discusses a trial of liraglutide versus colesevelam for the treatment of bile acid diarrhoea. Read the full article: Safety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: a randomised, double-blind, active-comparator, non-inferiority clinical trial Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicalj...
Edward Kim on radiation segmentectomy for unresectable very early to early stage hepatocellular carcinoma
August 04, 2022 13:00 - 14 minutes - 9.72 MBEdward Kim (Icahn School of Medicine at Mount Sinai) discusses the single-arm RASER study of radiation segmentectomy for patients with unresectable very early to early stage hepatocellular carcinoma. Read the full article: Radiation segmentectomy for curative intent of unresectable very early to early stage hepatocellular carcinoma (RASER): a single-centre, single-arm study Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thela...
Joep Ijspeert on serrated polyp detection and risk of interval post-colonoscopy colorectal cancer
July 06, 2022 22:00 - 10 minutes - 7.21 MBJoep Ijspeert (Amsterdam University Medical Center) discusses a population-based study exploring the detection of proximal serrated polyps and interval post-colonoscopy colorectal cancer risk. Read the full article: Serrated polyp detection and risk of interval post-colonoscopy colorectal cancer: a population-based study Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal...
Elise Meima-van Praag on surgical closure for Crohn’s disease perianal fistulas
June 14, 2022 15:00 - 9 minutes - 6.79 MBElise Meima-van Praag (Amsterdam University Medical Centre) discusses the PISA-II trial, investigating short-term anti-TNF therapy with surgical closure versus anti-TNF therapy for perianal fistulas in Crohn's disease. Read the full article: Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in Crohn's disease (PISA-II) Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com...
Juan Pablo Arab on NAFLD public health policies in the Americas
May 09, 2022 09:00 - 17 minutes - 11.8 MBJuan Pablo Arab (Catholic University of Chile) discusses the current burden of NAFLD and the landscape of public health policies related to the disease in the Americas. Read the full article: The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the Americas Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.c...
Sarah Blach on hepatitis C virus epidemiology
April 06, 2022 22:00 - 8 minutes - 6.18 MBSarah Blach (CDA Foundation) summarises the latest analysis of global hepatitis C virus epidemiology and cascade of care by the Polaris Observatory HCV Collaborators. Read the full article: Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/comp...
Sunil Solomon on a minimal monitoring approach for hepatitis C virus infection
March 23, 2022 10:00 - 15 minutes - 10.4 MBSunil Solomon (Johns Hopkins University) discusses a study of a minimal monitoring approach for treating patients with hepatitis C virus infection. Read the full article: A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://l...
Rupert Leong on oral faecal microbiota transplantation in ulcerative colitis
March 09, 2022 12:00 - 13 minutes - 9.45 MBRupert Leong (University of Sydney) discusses a new double-blind, randomised, placebo-controlled trial of oral faecal microbiota transplantation for patients with active ulcerative colitis. Read the full article: Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS) Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/compan...
Swati Patel on early-onset colorectal cancer
February 09, 2022 23:00 - 19 minutes - 13.4 MBSwati Patel (University of Colorado Anschutz Medical Center) discusses the epidemiology, clinical features, biology, risk factors, and opportunities for prevention and detection of early-onset colorectal cancers. Read the full article: The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection Continue this conversation on social! Follow us today at... https://twitter.com/thelancet http...
Emilie Breekveldt on FIT-based screening for colorectal cancer in the Netherlands
December 10, 2021 12:00 - 9 minutes - 6.66 MBEmilie Breekveldt (Erasmus Medical Center, Netherlands) discusses a new analysis of the faecal immunochemical testing-based colorectal screening programme in the Netherlands. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00368-X/fulltext Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet...
Wendy Spearman on non-alcoholic fatty liver disease in sub-Saharan Africa
November 11, 2021 23:00 - 22 minutes - 15.5 MBWendy Spearman (University of Cape Town) discusses a Series on the emergence of non-alcoholic fatty liver disease in Sub-Saharan Africa and the challenges it presents. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00296-X/fulltext Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https:/...
Tim Vanuytsel on spore-forming probiotics in functional dyspepsia
September 09, 2021 22:00 - 7 minutes - 4.87 MBTim Vanuytsel (University of Leuven) discusses a new trial of spore-forming probiotics in functional dyspepsia. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00226-0/fulltext Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Raymond Henderson on the economic burden of colorectal cancer
August 12, 2021 22:00 - 11 minutes - 7.82 MBRaymond Henderson (Queen’s University Belfast) discusses a new analysis of the economic burden of colorectal cancer in Europe. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00147-3/fulltext Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Sigurður Ólafsson on eliminating hepatitis C in Iceland
June 22, 2021 22:00 - 13 minutes - 9.07 MBSigurður Ólafsson (Landspitali University Hospital) discusses newly published results from the nationwide programme to eliminate hepatitis C virus in Iceland. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00137-0/fulltext Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube...
Caroline Ovadia on intrahepatic cholestasis of pregnancy
June 03, 2021 09:00 - 12 minutes - 8.56 MBCaroline Ovadia (King’s College London) discusses an individual participant data meta-analysis on the treatment of intrahepatic cholestasis of pregnancy with ursodeoxycholic acid. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00074-1/fulltext Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-la...
Matthew Akiyama on hepatitis C in prisons
April 12, 2021 22:00 - 7 minutes - 4.92 MBMatthew Akiyama (Montefiore Medical Center and Albert Einstein College of Medicine, USA) discusses a Review on hepatitis C elimination among people incarcerated in prisons. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(20)30365-4/fulltext Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet ht...
Monika Sarkar on reproductive health in women with liver disease
March 11, 2021 23:00 - 8 minutes - 5.7 MBMonika Sarkar (University of California San Francisco, USA) discusses her Comment on reproductive health in women with chronic liver disease. Read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00055-8/fulltext Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Colorectal cancer risk in patients with Crohn’s disease
March 12, 2020 14:00 - 6 minutes - 4.55 MBOla Olén discusses the assesment of colorectal cancer risk in patients with Crohn's disease. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Liver damage in young adults
January 17, 2020 08:00 - 6 minutes - 4.83 MBDr Kushala Abeysekara discusses research looking at the prevalence of non-alcoholic fatty liver disease in young adults in England. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Treatments for IBS
January 14, 2020 16:00 - 8 minutes - 5.73 MBProfessor Alexander Ford discusses a meta analysis comparing different traditional treatments for irritable bowel syndrome. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Statins and decompensated cirrhosis
November 27, 2019 08:00 - 6 minutes - 4.53 MBDr. Elisa Pose discusses the potential beneficial effects of statins on the treatment of patients with decompensated cirrhosis Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Global burden of pancreatic cancer and colorectal cancer
November 04, 2019 16:00 - 14 minutes - 9.93 MBMohsen Naghavi describes the key findings from two new Global Burden of Disease studies investigating the global burden of pancreatic cancer and colorectal cancer. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Paediatric inflammatory bowel disease
September 12, 2019 15:00 - 7 minutes - 5.13 MBViktor Wintzell joins The Lancet Gastroenterology & Hepatology to discuss the risk of serious infection after use of tumour necrosis factor-α inhibitors in children with inflammatory bowel disease. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Transplanting hepatitis C-infected hearts
August 28, 2019 07:00 - 6 minutes - 4.53 MBProf Raymond Chung discusses new research in transplantation of HCV-infected hearts. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Primary anastomosis as a treatment for diverticulitis
July 31, 2019 18:00 - 7 minutes - 5.28 MBDaniel Lambrichts joins The Lancet Gastroenterology & Hepatology to discuss different treatments for diverticulitis. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Faecal microbiota transplantation in IBS
July 30, 2019 07:00 - 6 minutes - 4.83 MBDr Olga Aroniaidis discusses the results of a newly published trial of FMT to treat IBS. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Treating faecal incontinence in women
July 17, 2019 08:00 - 8 minutes - 5.73 MBDr Eric Jelovsek discusses new research into the treatment of this important and often overlooked condition. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Viral hepatitis in children & adolescents
May 23, 2019 00:00 - 24 minutes - 17 MBPhilippa Easterbrook discusses a series of two Review articles on viral hepatitis in children and adolescents. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Whole-body MRI: the STREAMLINE trials
May 11, 2019 16:00 - 9 minutes - 6.63 MBStuart Taylor discusses the results of the STREAMLINE trials, which assessed the use of whole-body MRI to stage colorectal and lung cancers. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
A new drug for short bowel syndrome
April 05, 2019 22:30 - 11 minutes - 7.03 MBDr Rahim Naimi discusses the results of a phase 2 trial of glepaglutide to treat short bowel syndrome. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Eosinophilic oesophagitis endotype classification
March 09, 2019 15:00 - 9 minutes - 6.78 MBMarc Rothenberg joins The Lancet Gastroenterology & Hepatology to talk about eosinophilic oesophagitis endotype classification. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Acute hepatitis C
March 08, 2019 07:30 - 6 minutes - 4.53 MBBart Rijnders discusses his recent work on the treatment of people with acute hepatitis C. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Epidemiology of chronic liver disease
February 08, 2019 07:30 - 8 minutes - 6.03 MBJennifer Flemming talks with The Lancet Gastroenterology & Hepatology about recent developments in the field of chronic liver disease. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv